Stock listing

gettex:K27 Kodiak Sciences Inc Aktie

German listing (gettex) of Kodiak Sciences Inc · home listing NASDAQ:KOD

Follow Kodiak Sciences Inc into a list and get an email when it puts out news.

Home listing price · NASDAQ:KOD

$97.17 USD -0.64 (-0.7%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:KOD

Past year +396.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$96.53 – $100.89 USDNov 20, 2026
Volume
692,947 sharesNov 20, 2026
Market cap
$6.35B USDAt the close on Nov 20, 2026 · price × 65.40M shares outstanding
52-week range
$19.25 – $112.79 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$143.9M USDMedian day 926,851 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Kodiak Sciences Inc logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:KOD · Home$97.17 USD-0.64 (-0.7%)692,947$97.00$100.89$96.53$97.81Close on Nov 20, 2026
Frankfurt:K27€88.64 EUR0.00 (0.0%)—€88.48€88.64€88.48€88.64Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:KOD · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$97.17-0.64-0.7%$97.00$100.89$96.53692,947
$97.81+1.01+1.0%$96.51$99.74$95.58744,855
$96.80-3.93-3.9%$101.74$104.36$94.62819,712
$100.73-10.46-9.4%$108.93$110.49$100.36980,331
$111.19+2.94+2.7%$108.27$112.79$103.20970,455
$108.25-1.09-1.0%$108.19$110.97$106.36555,136
$109.34+1.28+1.2%$107.90$112.31$107.25689,206
$108.06+0.96+0.9%$106.70$109.20$104.49589,982
$107.10+7.80+7.9%$101.72$107.53$99.561,127,738
$99.30+8.28+9.1%$92.83$100.17$91.001,038,688
$91.02-7.49-7.6%$99.09$99.09$90.501,100,466
$98.51-0.38-0.4%$101.67$101.92$96.271,003,968
$98.89+1.265+1.3%$98.76$102.04$97.80803,361
$97.63-1.555-1.6%$99.31$100.63$94.77595,405
$99.18-1.22-1.2%$99.41$100.69$96.58567,495
$100.40+3.36+3.5%$96.07$103.73$96.001,172,788
$97.04+5.72+6.3%$90.41$97.79$90.00973,005
$91.32+1.72+1.9%$89.65$94.73$89.201,010,388
$89.60+1.97+2.2%$88.03$91.89$87.61926,851
$87.63+1.85+2.2%$85.13$87.85$83.16526,900
$85.78-1.94-2.2%$87.14$89.52$84.86593,600
$87.72-5.25-5.6%$91.14$94.64$87.29943,000
$92.97+1.62+1.8%$90.84$96.12$89.53865,900
$91.35+5.60+6.5%$86.84$92.74$86.501,047,600
$85.75-2.37-2.7%$87.18$89.78$85.201,122,100
$88.12+7.03+8.7%$81.30$88.50$79.061,394,700
$81.09-10.54-11.5%$90.62$90.62$80.142,405,300
$91.63-7.63-7.7%$99.29$99.55$91.271,535,800
$99.26-0.61-0.6%$100.08$103.27$97.021,324,700
$99.87+5.61+6.0%$94.97$100.33$93.701,732,500
$94.26+3.18+3.5%$90.01$94.95$89.541,527,700
$91.08-1.26-1.4%$91.74$94.25$89.911,305,100
$92.34-1.47-1.6%$92.86$95.54$89.701,479,600
$93.81-0.64-0.7%$92.86$96.64$87.583,234,600
$94.45-4.01-4.1%$98.95$98.95$88.632,674,700
$98.46+3.66+3.9%$95.41$104.00$93.953,792,100
$94.80+3.68+4.0%$93.83$98.80$88.484,920,000
$91.12+1.20+1.3%$87.20$93.14$83.646,047,100
$89.92+57.57+178.0%$61.71$95.77$60.4938,552,000
$32.35-0.87-2.6%$33.03$33.71$31.002,277,300
$33.22+1.70+5.4%$30.90$33.78$29.811,290,100
$31.52-2.28-6.7%$34.10$34.48$30.801,052,500
$33.80+1.38+4.3%$32.71$34.45$32.461,038,200
$32.42-0.29-0.9%$33.04$33.34$32.00666,200
$32.71-0.14-0.4%$32.78$32.82$31.541,608,900
$32.85+0.08+0.2%$33.32$33.69$32.73826,100
$32.77-0.22-0.7%$33.12$33.49$31.62707,900
$32.99-0.15-0.5%$32.71$33.29$32.38819,600
$33.14+0.25+0.8%$33.21$33.89$32.96547,600
$32.89+0.02+0.1%$33.10$34.07$32.31682,600
$32.87-0.91-2.7%$33.29$33.41$32.61668,200
$33.78-1.29-3.7%$35.00$35.93$33.73643,500
$35.07-0.29-0.8%$34.71$35.27$33.92673,200
$35.36-1.00-2.8%$35.98$36.62$35.18671,800
$36.36-1.14-3.0%$37.60$37.82$36.20460,200
$37.50+0.44+1.2%$37.44$39.54$36.61507,400
$37.06-0.29-0.8%$37.01$38.11$36.70391,600
$37.35-0.37-1.0%$37.28$37.76$35.501,151,500
$37.72-1.40-3.6%$38.73$39.62$37.40469,000
$39.12-0.21-0.5%$39.37$40.11$38.65474,900
$39.33-0.13-0.3%$39.94$40.03$38.40296,800
$39.46+2.24+6.0%$37.99$39.68$37.70571,300
$37.22-1.11-2.9%$38.33$38.90$36.46717,500
$38.33-1.51-3.8%$40.39$40.90$37.99509,100
$39.84-0.23-0.6%$39.50$40.52$38.69486,600
Ticker
gettex:K27
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
gettex
Currency
EUR

What changed lately

Latest news

All Kodiak Sciences Inc news

Kodiak Sciences Inc on 6ix

Sector
Health care
Industry
Biotechnology
News releases
18 in the last 12 months · 124 in all · newest Nov 12, 2026 · oldest 2019
Decks
40 decks · latest Sep 28, 2026

Where Kodiak Sciences Inc is listed

ListingExchangeCountryCurrency
NASDAQ:KOD · Home listingNASDAQUnited StatesUSD
LS Exchange:A2N6P0LS ExchangeGermanyEUR
gettex:K27 · This pagegettexGermanyEUR
Lang & Schwarz:A2N6P0Lang & SchwarzGermanyEUR
BIVA:KODBIVAMexicoMXN
BMV:KODBMVMexicoMXN
BOATS:KODBOATSUnited StatesUSD
Tradegate:K27TradegateGermanyEUR
Frankfurt:K27FrankfurtGermanyEUR
Dusseldorf:K27DusseldorfGermanyEUR
Munich:K27MunichGermanyEUR
Stuttgart:K27StuttgartGermanyEUR

Valuation

Price/book 505× against a median of 12.5×: the highest of 9 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$6.31B USD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
505×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
3.7×
Beta vs S&P 500
1.58

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Kodiak Sciences Inc · NASDAQ:KODUS$6.35BUS$6.31Bn/an/an/a505×n/a3.7×1.58
CG Oncology, Inc. · NASDAQ:CGONUS$7.10BUS$6.12Bn/a992×n/a7.2×n/a0.0×0.83
Cytokinetics, Incorporated · NASDAQ:CYTKUS$7.07BUS$6.36Bn/a56.2×n/an/a−686.6%n/a0.93
Axsome Therapeutics, Inc. · NASDAQ:AXSMUS$6.80BUS$6.68Bn/a7.7×n/a64.5×−18.2%1.8×0.69
Akeso, Inc. · HKEX:9926US$6.66BUS$6.04Bn/a13.5×n/a5.2×−36.4%0.6×n/a
Immunovant, Inc. · NASDAQ:IMVTUS$6.57BUS$5.85Bn/a825×n/a10.0×n/a0.0×1.46
Oruka Therapeutics, Inc. · NASDAQ:ORKAUS$6.50BUS$5.58Bn/an/an/a5.4×n/a0.0×1.30
ImmunityBio, Inc. · NASDAQ:IBRXUS$6.40BUS$6.10Bn/a33.4×n/an/a−607.8%n/a1.50
Abivax SA · EURONEXT:ABVXUS$6.05BUS$5.60Bn/an/an/a15.1×n/a0.0×n/a
Scholar Rock Holding Corporation · NASDAQ:SRRKUS$5.87BUS$5.65Bn/a9,921×n/a34.8×n/a1.2×0.91
Arrowhead Pharmaceuticals, Inc. · NASDAQ:ARWRUS$5.85BUS$4.66Bn/a10.3×n/a116×−160.6%0.0×1.34
Median of the othersUS$6.54BUS$5.95B44.8×12.5×−160.6%0.0×1.12

Forecasts

5 strong buy · 1 buy · 1 hold · Analysts' consensus from EODHD, read Nov 14, 2026. Not 6ix's view and not investment advice.

Price target
129.50 USD · Analysts' mean
EPS, year to Dec 2026
-4.00 · 2 analysts

Team and board

DirectorRole
Charles A. BancroftChair of the Audit Committee

Events

QuarterResultsShare move
Q3 2026Nov 12, 2026 · After close+2.7%
Q2 2026Aug 13, 2026 · After close+3.4%
Q1 2026May 7, 2026 · After close−6.1%
Q4 2025Mar 26, 2026+62.6%
Q3 2025Nov 13, 2025 · After close+3.4%
Q2 2025Aug 13, 2025 · After close+16.5%
Q1 2025May 14, 2025 · After close−15.5%
Q4 2024Mar 26, 2025 · Before open−6.1%
Q3 2024Nov 14, 2024 · After close+4.3%
Q2 2024Aug 14, 2024 · After close+1.6%
All 20 quarters
QuarterResultsShare move
Q1 2024May 15, 2024 · After close0.0%
Q4 2023Mar 28, 2024 · Before open−29.4%
Q3 2023Nov 14, 2023 · After close+5.2%
Q2 2023Aug 14, 2023 · After close−10.0%
Q1 2023May 15, 2023 · After close+10.4%
Q4 2022Mar 28, 2023 · After close+23.3%
Q3 2022Nov 9, 2022 · After close+5.8%
Q2 2022Aug 9, 2022 · After close+14.5%
Q1 2022May 10, 2022 · After close−7.6%
Q4 2021Mar 1, 2022 · After close+0.1%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (September 2026)Investor deck42 slidesSep 28, 2026
Investor Presentation (September 2026)Investor deck89 slidesSeptember 2026
Jefferies Global Healthcare Conference 2026Conference78 slidesJune 2026
44th Annual J.P. Morgan Healthcare Conference (January 2026)Conference99 slidesJan 12, 2026
Jefferies Global Healthcare Conference – London 2025Conference74 slidesNov 17, 2025
Investor Day (July 2025)Investor day120 slidesJul 16, 2025
International Ocular Inflammation Society 2025Conference39 slides2025
Technical Presentation (2025)Technical8 slides2025
43rd J.P. Morgan Healthcare Conference 2025Conference78 slidesJanuary 2025
Technical Presentation (2025)Technical32 slides2025
All 40 decks
DeckKindSlidesDate
Investor Day (September 2024)Investor day186 slidesSep 23, 2024
Clinical Trials at the Summit 2024Conference17 slidesJun 8, 2024
Jefferies Global Healthcare Conference 2024Conference28 slidesJune 2024
FY2023 Earnings PresentationEarnings19 slidesMar 28, 2024
Angiogenesis, Exudation, and Degeneration 2024Conference21 slidesFeb 3, 2024
42nd J.P. Morgan Healthcare Conference (January 2024)Conference30 slidesJanuary 2024
American Academy of Ophthalmology – Retina Subspecialty Day 2023Conference24 slidesNov 3, 2023
56th Annual Scientific Meeting of the Retina Society (October 2023)Conference20 slidesOct 13, 2023
56th Annual Scientific Meeting of the Retina Society (October 2023)Conference26 slidesOct 13, 2023
56th Annual Scientific Meeting of the Retina Society (October 2023)Conference19 slidesOct 13, 2023
41st Annual Scientific Meeting of the American Society of Retina Specialists (July 2023)Conference23 slidesJul 30, 2023
Clinical Trials at the Summit 2023Conference16 slidesJun 10, 2023
Jefferies Healthcare Conference 2023Conference21 slidesJune 2023
Angiogenesis, Exudation, and Degeneration 2023Conference21 slidesFeb 11, 2023
2022 American Academy of Ophthalmology Annual MeetingConference23 slidesSep 30, 2022
22nd EURETINA Congress (September 2022)Conference25 slidesSep 2, 2022
Shareholder Meeting (October 2021)Shareholder meeting14 slidesOct 5, 2021
Barclays Global Healthcare Conference 2021Conference63 slidesMar 10, 2021
Angiogenesis, Exudation, and Degeneration 2021Conference38 slidesFeb 13, 2021
J.P. Morgan Annual Healthcare Conference 2021Conference25 slidesJan 11, 2021
AAO – Retina Subspecialty Day 2020Conference30 slidesNov 11, 2020
Angiogenesis, Exudation, and Degeneration 2020Conference26 slidesFeb 8, 2020
AAO Annual Meeting – Retina Subspecialty Day 2019Conference29 slidesOct 11, 2019
Retina Society Annual Meeting 2019Conference19 slidesSep 15, 2019
EURetina 2019 CongressConference22 slidesSep 8, 2019
EURetina 2019 CongressConference22 slidesSep 5, 2019
American Society of Retina Specialists Annual Meeting 2019Conference19 slidesJul 27, 2019
Angiogenesis, Exudation, and Degeneration 2019Conference21 slidesFeb 9, 2019
Technical PresentationTechnical14 slides
Technical PresentationTechnical13 slides

Open Decks

Financings

RaiseDate
At-the-market programme of common stock
Closed: US$69M raised
Nov 12, 2026
Public offering of common stock
Closed: US$184M raised · US$23 a share · J.P. Morgan +3
Dealers: J.P. Morgan (co-lead), Jefferies (co-lead), Evercore ISI (co-lead), UBS Investment Bank (co-lead)
Use of proceeds: Strengthens financial position through Phase 3 topline readouts for KSI-101, KSI-501 and tarcocimab
Dec 18, 2025

Open Financings · Read by 6ix AI from the company's releases

IPO

Priced at US$10.00 a share on Oct 3, 2018.

Price
US$10.00 a share
Shares offered
9,000,000 shares of common stock
Offering size
US$90 million
Underwriters' option
Up to 1,350,000 more shares
Underwriters
Morgan Stanley, BofA Merrill Lynch, Barclays, Chardan · In the order on the cover
Shares delivered
On or about Oct 9, 2018

Steps

StepWhen
Draft sent to the SEC in confidenceFeb 14, 2018
Filed publiclySep 7, 2018
Amended 3 timesNewest Oct 1, 2018
Shares registered with an exchangeOct 1, 2018
Declared effective by the SECOct 3, 2018
Final prospectus, with the priceOct 5, 2018

Open IPO · From the cover of the final prospectus (424B4) filed Oct 5, 2018

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue0000000000
Cost of revenue26.7M25.9M11.0M8.71M4.21M911.0K490.0K549.0K257.0K
Gross profit-26.7M-25.9M-11.0M-8.71M-4.21M-911.0K-490.0K-549.0K-257.0K
Research and development182.4M126.1M206.3M267.6M217.3M107.4M37.5M18.8M22.0M14.1M
Selling, general and administrative52.0M60.8M71.0M73.8M49.7M28.6M11.7M7.58M3.50M3.10M
Operating income-234.4M-186.8M-277.3M-341.4M-267.1M-136.0M-49.2M-26.4M-25.5M-17.2M
Depreciation and amortization18.3M18.7M18.3M3.80M1.00M477.0K538.0K490.0K549.0K257.0K
EBITDA-216.1M-168.1M-259.0M-337.6M-266.0M-135.5M-48.7M-25.9M-25.0M-16.9M
Interest expense0013.0K18.0K47.0K25.0K8.00K5.52M1.19M6.00K
Income before tax-229.9M-176.2M-260.4M-333.8M-266.9M-133.1M-47.4M-41.4M-27.9M-17.1M
Income tax52.0K20.0K33.0K33.0K74.0K14.0K-638.0K-9.55M-45.0K31.0K
Net income-230.0M-176.2M-260.5M-333.8M-267.0M-133.1M-47.4M-41.4M-27.9M-17.1M
Earnings per share, basic-4.32-3.35-4.97-6.39-5.16-2.91-1.25-2.77-3.72-2.38
Earnings per share, diluted-4.32-3.35-4.97-6.39-5.16-2.91-1.25-2.77-3.72-2.38

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents209.9M168.1M285.5M190.4M731.5M944.4M211.8M88.3M1.40M9.62M
Short-term investments0288.5M024.6M124.7M
Current assets214.8M171.9M289.3M486.0M734.8M972.0M339.2M90.4M1.59M10.2M
Property, plant and equipment85.3M102.2M120.5M56.4M41.3M5.14M996.0K1.10M1.51M1.78M
Total assets351.5M335.6M479.4M666.6M904.2M1.07B358.9M92.2M3.24M12.1M
Accounts payable12.9M3.92M13.6M9.13M12.4M8.65M2.62M1.05M3.36M1.07M
Current liabilities45.5M25.6M41.7M52.5M64.7M31.4M11.7M4.83M9.16M2.51M
Long-term debt9.92M103.0K
Total debt159.2M70.3M181.6M187.7M179.9M77.4M1.94M12.4M185.0K
Total liabilities194.2M185.3M213.6M230.5M240.9M206.6M13.5M5.36M22.0M53.2M
Shareholders' equity157.4M150.3M265.8M436.2M663.3M860.8M345.4M86.8M-68.7M-41.1M
Shares outstanding61.8M52.7M52.5M52.3M51.8M51.1M44.4M36.8M7.94M44.4M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-136.0M-117.3M-154.2M-206.5M-182.3M-83.4M-39.1M-29.0M-17.7M-16.0M
Capital spending-506.0K-375.0K-41.4M-37.0M-17.0M-3.81M-437.0K-78.0K-209.0K-771.0K
Free cash flow-136.5M-117.7M-195.5M-243.5M-199.3M-87.2M-39.6M-29.1M-17.9M-16.8M
Cash from investing-506.0K-755.0K249.2M-336.5M-38.8M104.8M-137.0M-581.0K-209.0K-771.0K
Cash from financing178.3M501.0K31.0K1.90M8.18M717.4M299.7M116.5M9.64M-120.0K
Dividends paid-7.91M-10.0M-6.25M-2.29M
Share buybacks174.0K484.0K-487.0K-132.0K00-4.00K
Change in cash41.8M-117.6M95.1M-541.1M-212.9M738.8M123.5M86.9M-8.23M-16.9M

Open Financials

Filings

FilingDateTypeFiled with
SCHEDULE 13G/A · Big-stake notice, amendedNov 16, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 16, 2026Big-stake noticeSEC
10-Q · Quarterly reportNov 12, 2026Quarterly reportSEC
8-K · Current reportNov 12, 2026ResultsSEC
4 · Change in ownershipNov 6, 2026Insider tradeSEC
4 · Change in ownershipOct 26, 2026Insider tradeSEC
4 · Change in ownershipOct 23, 2026Insider tradeSEC
144 · Notice of proposed saleOct 21, 2026Other filingsSEC
S-3ASR · Registration statementOct 20, 2026Offer documentSEC
SCHEDULE 13D/A · Big-stake notice, amendedSep 30, 2026Big-stake noticeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipSep 30, 2026Insider tradeSEC
4 · Change in ownershipSep 30, 2026Insider tradeSEC
4 · Change in ownershipSep 30, 2026Insider tradeSEC
4 · Change in ownershipSep 29, 2026Insider tradeSEC
8-K · Current reportSep 28, 2026Current reportSEC
SCHEDULE 13G · Big-stake noticeAug 14, 2026Big-stake noticeSEC
10-Q · Quarterly reportAug 13, 2026Quarterly reportSEC
8-K · Current reportAug 13, 2026ResultsSEC
4 · Change in ownershipJul 17, 2026Insider tradeSEC
4 · Change in ownershipJul 17, 2026Insider tradeSEC
4 · Change in ownershipJul 2, 2026Insider tradeSEC
4 · Change in ownershipJul 2, 2026Insider tradeSEC
4 · Change in ownershipJul 2, 2026Insider tradeSEC
4 · Change in ownershipJul 2, 2026Insider tradeSEC
4 · Change in ownershipJul 2, 2026Insider tradeSEC
4 · Change in ownershipJul 2, 2026Insider tradeSEC
4 · Change in ownershipJun 5, 2026Insider tradeSEC
8-K · Current reportJun 4, 2026Meeting outcomeSEC
144 · Notice of proposed saleJun 4, 2026Other filingsSEC
SCHEDULE 13G · Big-stake noticeMay 15, 2026Big-stake noticeSEC
10-Q · Quarterly reportMay 7, 2026Quarterly reportSEC
8-K · Current reportMay 7, 2026ResultsSEC
SCHEDULE 13G · Big-stake noticeApr 27, 2026Big-stake noticeSEC
ARS · Annual report to shareholdersApr 22, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 22, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 22, 2026Meeting noticeSEC
4 · Change in ownershipApr 16, 2026Insider tradeSEC
4 · Change in ownershipApr 2, 2026Insider tradeSEC
144 · Notice of proposed saleApr 2, 2026Other filingsSEC
SCHEDULE 13G · Big-stake noticeApr 2, 2026Big-stake noticeSEC
S-8 · Registration statement for employee plansMar 31, 2026Offer documentSEC
10-K · Annual reportMar 31, 2026Annual reportSEC
8-K · Current reportMar 31, 2026ResultsSEC
4 · Change in ownershipMar 27, 2026Insider tradeSEC
8-K · Current reportMar 26, 2026Current reportSEC
4 · Change in ownershipMar 19, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 17, 2026Big-stake noticeSEC
5 · Annual statement of ownershipFeb 17, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 17, 2026Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedDec 19, 2025Big-stake noticeSEC
4 · Change in ownershipDec 19, 2025Insider tradeSEC
8-K · Current reportDec 18, 2025Current reportSEC
424B5 · ProspectusDec 17, 2025Offer documentSEC
424B5 · ProspectusDec 15, 2025Offer documentSEC
10-Q · Quarterly reportNov 13, 2025Quarterly reportSEC
8-K · Current reportNov 13, 2025ResultsSEC
SCHEDULE 13G · Big-stake noticeAug 19, 2025Big-stake noticeSEC
10-Q · Quarterly reportAug 13, 2025Quarterly reportSEC
8-K · Current reportAug 13, 2025ResultsSEC
4 · Change in ownershipJul 8, 2025Insider tradeSEC
4 · Change in ownershipJul 8, 2025Insider tradeSEC
4 · Change in ownershipJul 2, 2025Insider tradeSEC
4 · Change in ownershipJul 2, 2025Insider tradeSEC
4 · Change in ownershipJul 2, 2025Insider tradeSEC
4 · Change in ownershipJul 2, 2025Insider tradeSEC
4 · Change in ownershipJul 2, 2025Insider tradeSEC
4 · Change in ownershipJul 2, 2025Insider tradeSEC
4 · Change in ownershipJun 17, 2025Insider tradeSEC
8-K · Current reportJun 3, 2025Meeting outcomeSEC
10-Q · Quarterly reportMay 14, 2025Quarterly reportSEC
8-K · Current reportMay 14, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedApr 29, 2025Big-stake noticeSEC
ARS · Annual report to shareholdersApr 22, 2025Annual reportSEC
DEFA14A · Additional proxy materialApr 22, 2025Meeting noticeSEC
DEF 14A · Proxy statementApr 22, 2025Meeting noticeSEC
S-8 · Registration statement for employee plansMar 27, 2025Offer documentSEC
10-K · Annual reportMar 27, 2025Annual reportSEC
8-K · Current reportMar 27, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
10-Q · Quarterly reportNov 14, 2024Quarterly reportSEC
8-K · Current reportNov 14, 2024ResultsSEC
10-Q · Quarterly reportAug 14, 2024Quarterly reportSEC
8-K · Current reportAug 14, 2024ResultsSEC
4 · Change in ownershipAug 7, 2024Insider tradeSEC
4 · Change in ownershipAug 7, 2024Insider tradeSEC
4 · Change in ownershipJul 2, 2024Insider tradeSEC
4 · Change in ownershipJul 1, 2024Insider tradeSEC
4 · Change in ownershipJul 1, 2024Insider tradeSEC
4 · Change in ownershipJul 1, 2024Insider tradeSEC
4 · Change in ownershipJul 1, 2024Insider tradeSEC
4 · Change in ownershipJul 1, 2024Insider tradeSEC
4 · Change in ownershipJun 18, 2024Insider tradeSEC
4 · Change in ownershipJun 13, 2024Insider tradeSEC
8-K · Current reportJun 6, 2024Meeting outcomeSEC
10-Q · Quarterly reportMay 15, 2024Quarterly reportSEC
8-K · Current reportMay 15, 2024ResultsSEC
ARS · Annual report to shareholdersApr 23, 2024Annual reportSEC
DEFA14A · Additional proxy materialApr 23, 2024Meeting noticeSEC
DEF 14A · Proxy statementApr 23, 2024Meeting noticeSEC
S-8 · Registration statement for employee plansMar 28, 2024Offer documentSEC
10-K · Annual reportMar 28, 2024Annual reportSEC
8-K · Current reportMar 28, 2024ResultsSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedJan 26, 2024Big-stake noticeSEC
10-Q · Quarterly reportNov 14, 2023Quarterly reportSEC
8-K · Current reportNov 14, 2023ResultsSEC
8-K · Current reportNov 6, 2023Current reportSEC
8-K · Current reportAug 17, 2023Management or board changeSEC
10-Q · Quarterly reportAug 14, 2023Quarterly reportSEC
8-K · Current reportAug 14, 2023ResultsSEC
8-K · Current reportJul 24, 2023ResultsSEC
4 · Change in ownershipJul 5, 2023Insider tradeSEC
4 · Change in ownershipJul 3, 2023Insider tradeSEC
4 · Change in ownershipJul 3, 2023Insider tradeSEC
4 · Change in ownershipJul 3, 2023Insider tradeSEC
4 · Change in ownershipJul 3, 2023Insider tradeSEC
4 · Change in ownershipJul 3, 2023Insider tradeSEC
4 · Change in ownershipJun 27, 2023Insider tradeSEC
4 · Change in ownershipJun 27, 2023Insider tradeSEC
4 · Change in ownershipJun 27, 2023Insider tradeSEC
4 · Change in ownershipJun 16, 2023Insider tradeSEC
4 · Change in ownershipJun 16, 2023Insider tradeSEC
4 · Change in ownershipJun 13, 2023Insider tradeSEC
4 · Change in ownershipJun 13, 2023Insider tradeSEC
8-K · Current reportJun 7, 2023Meeting outcomeSEC
EFFECT · Notice that a registration is effectiveJun 5, 2023Other filingsSEC
CORRESP · Letter to the SECMay 31, 2023Other filingsSEC
UPLOAD · Letter from the SECMay 22, 2023Other filingsSEC
EFFECT · Notice that a registration is effectiveMay 18, 2023Other filingsSEC
CORRESP · Letter to the SECMay 15, 2023Other filingsSEC
S-3 · Registration statementMay 15, 2023Offer documentSEC
10-Q · Quarterly reportMay 15, 2023Quarterly reportSEC
8-K · Current reportMay 15, 2023ResultsSEC
ARS · Annual report to shareholdersApr 25, 2023Annual reportSEC
DEFA14A · Additional proxy materialApr 25, 2023Meeting noticeSEC
DEF 14A · Proxy statementApr 25, 2023Meeting noticeSEC
UPLOAD · Letter from the SECApr 5, 2023Other filingsSEC
S-3 · Registration statementMar 31, 2023Offer documentSEC
S-8 · Registration statement for employee plansMar 28, 2023Offer documentSEC
10-K · Annual reportMar 28, 2023Annual reportSEC
8-K · Current reportMar 28, 2023ResultsSEC
5 · Annual statement of ownershipFeb 14, 2023Insider tradeSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2023Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2023Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 9, 2023Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 3, 2023Big-stake noticeSEC
10-Q · Quarterly reportNov 9, 2022Quarterly reportSEC
8-K · Current reportNov 9, 2022ResultsSEC
10-Q · Quarterly reportAug 9, 2022Quarterly reportSEC
8-K · Current reportAug 9, 2022ResultsSEC
8-K · Current reportAug 8, 2022Current reportSEC
4 · Change in ownershipJul 8, 2022Insider tradeSEC
4 · Change in ownershipJul 8, 2022Insider tradeSEC
4 · Change in ownershipJul 8, 2022Insider tradeSEC
4 · Change in ownershipJul 5, 2022Insider tradeSEC
4 · Change in ownershipJul 5, 2022Insider tradeSEC
4 · Change in ownershipJul 5, 2022Insider tradeSEC
4 · Change in ownershipJul 5, 2022Insider tradeSEC
4 · Change in ownershipJul 5, 2022Insider tradeSEC
4 · Change in ownershipJul 5, 2022Insider tradeSEC
4 · Change in ownershipJun 17, 2022Insider tradeSEC
4 · Change in ownershipJun 17, 2022Insider tradeSEC
4 · Change in ownershipJun 14, 2022Insider tradeSEC
4 · Change in ownershipJun 14, 2022Insider tradeSEC
8-K · Current reportJun 7, 2022Meeting outcomeSEC
SC 13D/A · Big-stake notice, amendedJun 6, 2022Big-stake noticeSEC
4 · Change in ownershipJun 6, 2022Insider tradeSEC
4 · Change in ownershipMay 27, 2022Insider tradeSEC
4 · Change in ownershipMay 18, 2022Insider tradeSEC
SC 13D/A · Big-stake notice, amendedMay 18, 2022Big-stake noticeSEC
S-8 · Registration statement for employee plansMay 10, 2022Offer documentSEC
8-K · Current reportMay 10, 2022ResultsSEC
10-Q · Quarterly reportMay 10, 2022Quarterly reportSEC
DEFA14A · Additional proxy materialApr 28, 2022Meeting noticeSEC
DEF 14A · Proxy statementApr 28, 2022Meeting noticeSEC
SC 13G/A · Big-stake notice, amendedMar 10, 2022Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedMar 10, 2022Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedMar 9, 2022Big-stake noticeSEC
10-K · Annual reportMar 1, 2022Annual reportSEC
8-K · Current reportMar 1, 2022ResultsSEC
4 · Change in ownershipFeb 28, 2022Insider tradeSEC
8-K · Current reportFeb 23, 2022ResultsSEC
4 · Change in ownershipFeb 18, 2022Insider tradeSEC
4 · Change in ownershipFeb 18, 2022Insider tradeSEC
4 · Change in ownershipFeb 18, 2022Insider tradeSEC
4 · Change in ownershipFeb 17, 2022Insider tradeSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2022Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2022Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 10, 2022Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 4, 2022Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 3, 2022Big-stake noticeSEC
SC 13D/A · Big-stake notice, amendedJan 31, 2022Big-stake noticeSEC
4 · Change in ownershipJan 31, 2022Insider tradeSEC
4 · Change in ownershipJan 25, 2022Insider tradeSEC
4 · Change in ownershipJan 24, 2022Insider tradeSEC
4 · Change in ownershipDec 22, 2021Insider tradeSEC
S-8 · Registration statement for employee plansDec 15, 2021Offer documentSEC
4 · Change in ownershipNov 24, 2021Insider tradeSEC
4 · Change in ownershipNov 12, 2021Insider tradeSEC
10-Q · Quarterly reportNov 9, 2021Quarterly reportSEC

This page holds 200 of 427 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Kodiak Sciences Inc’s releases · as of Nov 12, 2026

Common shares
65,395,553
Fully diluted
65,395,553

Fully diluted

LineSharesAs of
Common shares65,395,553Nov 9, 2026

Share count over time

CountShares
Nov 9, 202665,395,553

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Baker Bros. Advisors LP21.9M33.4%US$2.07BSep 30, 2026
T. Rowe Price4.9M7.5%US$465MSep 30, 2026
BlackRock3.81M5.8%US$362MSep 30, 2026
Vanguard2.63M4.0%US$249MSep 30, 2026
State Street2.23M3.4%US$211MSep 30, 2026
Goldman Sachs1.99M3.0%US$189MSep 30, 2026
Janus Henderson1.88M2.9%US$178MSep 30, 2026
Rtw Investments, LP1.49M2.3%US$141MSep 30, 2026
Boxer Capital Management, LLC1.48M2.3%US$140MSep 30, 2026
TCG Crossover Management, LLC1.45M2.2%US$137MSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Braidwell LP1.09M1.7%US$103MSep 30, 2026
Geode Capital1.04M1.6%US$98.9MSep 30, 2026
Adage Capital Partners Gp, L.L.C.1M1.5%US$94.8MSep 30, 2026
Artisan Partners Limited Partnership836K1.3%US$79.3MSep 30, 2026
Citadel781K1.2%US$74MSep 30, 2026
Silverarc Capital Management, LLC750K1.1%US$71.1MSep 30, 2026
Wellington715K1.1%US$67.8MSep 30, 2026
Board of Trustees of The Leland Stanford Junior University692K1.1%US$65.6MSep 30, 2026
Ikarian Capital, LLC533K0.82%US$50.5MSep 30, 2026
Bank of America492K0.75%US$46.7MSep 30, 2026
Bellevue Group AG460K0.70%US$43.6MSep 30, 2026
Fidelity438K0.67%US$41.5MSep 30, 2026
Squadron Capital Management LLC420K0.64%US$39.8MSep 30, 2026
Schwab374K0.57%US$35.4MSep 30, 2026
Northern Trust347K0.53%US$32.9MSep 30, 2026
Morgan Stanley298K0.46%US$28.2MSep 30, 2026
Soleus Capital Management, L.P.287K0.44%US$27.2MSep 30, 2026
Dimensional263K0.40%US$24.9MSep 30, 2026
UBS236K0.36%US$22.4MSep 30, 2026
Ghisallo Capital Management LLC200K0.31%US$19MSep 30, 2026
TD199K0.30%US$18.2MSep 30, 2026
Two Sigma194K0.30%US$18.4MSep 30, 2026
Parkman Healthcare Partners LLC186K0.28%US$17.6MSep 30, 2026
JPMorgan164K0.25%US$15.1MSep 30, 2026
Schonfeld Strategic Advisors LLC153K0.23%US$14.5MSep 30, 2026
Susquehanna143K0.22%US$13.6MSep 30, 2026
D. E. Shaw & Co., Inc.140K0.21%US$13.2MSep 30, 2026
Franklin Templeton137K0.21%US$13.5MSep 30, 2026
Boothbay Fund Management, LLC136K0.21%US$12.9MSep 30, 2026
Atom Investors LP132K0.20%US$12.5MSep 30, 2026
Bruce & Co., Inc.130K0.20%US$12.3MSep 30, 2026
Nuveen120K0.18%US$11.4MSep 30, 2026
Eventide Asset Management, LLC116K0.18%US$11MSep 30, 2026
Federated Hermes, Inc.111K0.17%US$10.6MSep 30, 2026
PFM Health Sciences, LP110K0.17%US$10.4MSep 30, 2026
BNY107K0.16%US$10.1MSep 30, 2026
Marshall Wace, LLP101K0.15%US$9.58MSep 30, 2026
Arrowstreet Capital, Limited Partnership101K0.15%US$9.57MSep 30, 2026
Algert Global LLC100K0.15%US$9.5MSep 30, 2026
Manufacturers Life Insurance Company, The99,7350.15%US$9.45MSep 30, 2026

This page holds 50 of 207 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
State Street(R) SPDR(R) S&P(R) Biotech ETF1.5M2.3%US$58.3MJun 30, 2026
Vanguard Total Stock Market Index Fund1.29M2.0%US$50.2MJun 30, 2026
iShares Russell 2000 ETF1.02M1.6%US$39.8MJun 30, 2026
T. Rowe Price Health Sciences Fund, Inc.1.01M1.6%US$39.5MJun 30, 2026
Artisan International Small-Mid Fund596K0.91%US$23.2MJun 30, 2026
T. Rowe Price New Horizons Fund, Inc.591K0.90%US$23MJun 30, 2026
T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund498K0.76%US$19.4MJun 30, 2026
Vanguard Extended Market Index Fund476K0.73%US$18.5MJun 30, 2026
Fidelity Small Cap Index Fund430K0.66%US$17.9MJul 31, 2026
T. Rowe Price Small-Cap Stock Fund, Inc.426K0.65%US$16.6MJun 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
iShares Biotechnology ETF410K0.63%US$16MJun 30, 2026
iShares Russell 2000 Growth ETF347K0.53%US$13.5MJun 30, 2026
T. Rowe Price Small-Cap Value Fund, Inc.268K0.41%US$10.4MJun 30, 2026
Vanguard Explorer Fund246K0.38%US$10.2MJul 31, 2026
T. Rowe Price Institutional Small-Cap Stock Fund229K0.35%US$8.93MJun 30, 2026
Fidelity Extended Market Index Fund208K0.32%US$7.63MMay 31, 2026
Vanguard Russell 2000 Index Fund194K0.30%US$7.14MMay 31, 2026
Schwab U.S. Small-Cap ETF194K0.30%US$7.12MMay 31, 2026
Fidelity Enhanced Small Cap Core ETF160K0.24%US$6.23MJun 30, 2026
Invesco Dorsey Wright SmallCap Momentum ETF156K0.24%US$5.72MMay 31, 2026
Bruce Fund145K0.22%US$5.65MJun 30, 2026
Federated Hermes MDT Small Cap Core Fund144K0.22%US$5.99MJul 31, 2026
U.S. Small Cap Portfolio134K0.20%US$5.57MJul 31, 2026
BlackRock Health Sciences Opportunities Portfolio129K0.20%US$4.72MMay 29, 2026
Schwab Small-Cap Index Fund95,6270.15%US$3.98MJul 31, 2026
BlackRock Advantage Small Cap Core Fund89,5100.14%US$3.29MMay 29, 2026
Fidelity Advisor Biotechnology Fund88,3000.14%US$3.67MJul 31, 2026
Vanguard Health Care Index Fund87,1350.13%US$3.2MMay 31, 2026
T. Rowe Price Small-Mid Cap ETF82,9790.13%US$3.23MJun 30, 2026
North Square Dynamic Small Cap Fund76,8900.12%US$2.82MMay 31, 2026
Fidelity Total Market Index Fund75,4390.12%US$2.77MMay 31, 2026
Small Cap Growth Stock Portfolio74,6770.11%US$2.91MJun 30, 2026
Nuveen Equity Index Fund74,4330.11%US$3.09MJul 31, 2026
Master Small Cap Index Series72,6460.11%US$2.83MJun 30, 2026
VictoryShares US Small Mid Cap Value Momentum ETF72,0150.11%US$2.81MJun 30, 2026
Vanguard U.S. Momentum Factor ETF70,3770.11%US$2.58MMay 31, 2026
T. Rowe Price Health Sciences Portfolio64,0060.10%US$2.49MJun 30, 2026
Fidelity Series Total Market Index Fund61,0980.09%US$2.24MMay 31, 2026
iShares Core S&P Total U.S. Stock Market ETF60,8300.09%US$2.37MJun 30, 2026
Small Company Growth Portfolio56,5670.09%US$2.2MJun 30, 2026
T.Rowe Price Small Cap Growth Portfolio55,7980.09%US$2.17MJun 30, 2026
Hartford Small Cap Growth Hls Fund54,4390.08%US$2.12MJun 30, 2026
T. Rowe Price Integrated U.S. Small-Mid Cap Core Equity Fund53,9300.08%US$2.1MJun 30, 2026
Direxion Daily S&P Biotech Bull 3X Shares50,8080.08%US$2.11MJul 31, 2026
Invesco RAFI US 1500 Small-Mid ETF49,6510.08%US$2.06MJul 31, 2026
Nuveen Small Cap Blend Index Fund48,5860.07%US$2.02MJul 31, 2026
Goldman Sachs Small Cap Equity Insights Fund47,3540.07%US$1.97MJul 31, 2026
Goldman Sachs Small Cap Value Insights Fund45,3710.07%US$1.89MJul 31, 2026
EQ/2000 Managed Volatility Portfolio42,6200.07%US$1.66MJun 30, 2026
Fidelity Small Cap Growth Index Fund36,8860.06%US$1.44MJun 30, 2026

This page holds 50 of 214 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Baker Bros. Advisors LP
Director, 10% owner
Buy4,703USD 98.51US$463KNov 5, 2026
Baker Bros. Advisors LP
Director, 10% owner
Buy81,729USD 98.51US$8.05MNov 5, 2026
Baker Bros. Advisors LP
Director, 10% owner
Buy8,742USD 98.51US$861KNov 4, 2026
Baker Bros. Advisors LP
Director, 10% owner
Buy151,916USD 98.51US$15MNov 4, 2026
Borgeson John A.
Officer: Chief Financial Officer
Sale8,514USD 87.67US$746KOct 21, 2026
Borgeson John A.
Officer: Chief Financial Officer
Sale1,677USD 89.20US$150KOct 21, 2026
Borgeson John A.
Officer: Chief Financial Officer
Sale7,623USD 89.74US$684KOct 21, 2026
Borgeson John A.
Officer: Chief Financial Officer
Sale5,101USD 90.98US$464KOct 21, 2026
Borgeson John A.
Officer: Chief Financial Officer
Sale2,985USD 91.76US$274KOct 21, 2026
Borgeson John A.
Officer: Chief Financial Officer
Sale2,000USD 92.66US$185KOct 21, 2026
Show 50 trades
TradeTradeSharesPriceValueDate
Borgeson John A.
Officer: Chief Financial Officer
Sale2,000USD 93.71US$187KOct 21, 2026
Borgeson John A.
Officer: Chief Financial Officer
Sale100USD 94.91US$9,491Oct 21, 2026
667, L.P.
Director, 10% owner
Buy619USD 84.24US$52,145Sep 29, 2026
667, L.P.
Director, 10% owner
Buy10,381USD 84.24US$874KSep 29, 2026
667, L.P.
Director, 10% owner
Buy1,195USD 85.40US$102KSep 29, 2026
667, L.P.
Director, 10% owner
Buy20,031USD 85.40US$1.71MSep 29, 2026
667, L.P.
Director, 10% owner
Buy84USD 85.89US$7,215Sep 29, 2026
667, L.P.
Director, 10% owner
Buy1,416USD 85.89US$122KSep 29, 2026
Baker Bros. Advisors (GP) LLC
Director, 10% owner
Buy856USD 61.21US$52,396Sep 28, 2026
Baker Bros. Advisors (GP) LLC
Director, 10% owner
Buy14,344USD 61.21US$878KSep 28, 2026
Baker Bros. Advisors (GP) LLC
Director, 10% owner
Buy2,666USD 61.63US$164KSep 28, 2026
Baker Bros. Advisors (GP) LLC
Director, 10% owner
Buy44,690USD 61.63US$2.75MSep 28, 2026
Baker Bros. Advisors (GP) LLC
Director, 10% owner
Buy243USD 62.96US$15,299Sep 28, 2026
Baker Bros. Advisors (GP) LLC
Director, 10% owner
Buy4,067USD 62.96US$256KSep 28, 2026
Baker Bros. Advisors (GP) LLC
Director, 10% owner
Buy479USD 64.43US$30,862Sep 28, 2026
Baker Bros. Advisors (GP) LLC
Director, 10% owner
Buy8,021USD 64.43US$517KSep 28, 2026
Baker Bros. Advisors (GP) LLC
Director, 10% owner
Buy321USD 67.10US$21,539Sep 28, 2026
Baker Bros. Advisors (GP) LLC
Director, 10% owner
Buy5,382USD 67.10US$361KSep 28, 2026
Baker Bros. Advisors (GP) LLC
Director, 10% owner
Buy154USD 68.37US$10,529Sep 28, 2026
Baker Bros. Advisors (GP) LLC
Director, 10% owner
Buy2,585USD 68.37US$177KSep 28, 2026
Baker Bros. Advisors (GP) LLC
Director, 10% owner
Buy2,331USD 68.96US$161KSep 28, 2026
Baker Bros. Advisors (GP) LLC
Director, 10% owner
Buy39,066USD 68.96US$2.69MSep 28, 2026
Baker Bros. Advisors (GP) LLC
Director, 10% owner
Buy1,056USD 71.48US$75,483Sep 28, 2026
Baker Bros. Advisors (GP) LLC
Director, 10% owner
Buy17,698USD 71.48US$1.27MSep 28, 2026
Baker Bros. Advisors (GP) LLC
Director, 10% owner
Buy16,641USD 72.39US$1.2MSep 28, 2026
Baker Bros. Advisors (GP) LLC
Director, 10% owner
Buy278,978USD 72.39US$20.2MSep 28, 2026
Baker Bros. Advisors (GP) LLC
Director, 10% owner
Buy4,696USD 73.08US$343KSep 28, 2026
Baker Bros. Advisors (GP) LLC
Director, 10% owner
Buy78,726USD 73.08US$5.75MSep 28, 2026
Baker Bros. Advisors (GP) LLC
Director, 10% owner
Buy4,577USD 73.97US$339KSep 28, 2026
Baker Bros. Advisors (GP) LLC
Director, 10% owner
Buy76,723USD 73.97US$5.68MSep 28, 2026
Baker Bros. Advisors (GP) LLC
Director, 10% owner
Buy1,924USD 75.52US$145KSep 28, 2026
Baker Bros. Advisors (GP) LLC
Director, 10% owner
Buy32,261USD 75.52US$2.44MSep 28, 2026
Baker Bros. Advisors (GP) LLC
Director, 10% owner
Buy3,681USD 76.35US$281KSep 28, 2026
Baker Bros. Advisors (GP) LLC
Director, 10% owner
Buy61,700USD 76.35US$4.71MSep 28, 2026
Baker Bros. Advisors (GP) LLC
Director, 10% owner
Buy2,884USD 77.43US$223KSep 28, 2026
Baker Bros. Advisors (GP) LLC
Director, 10% owner
Buy48,350USD 77.43US$3.74MSep 28, 2026
Baker Bros. Advisors (GP) LLC
Director, 10% owner
Buy2,969USD 78.57US$233KSep 28, 2026
Baker Bros. Advisors (GP) LLC
Director, 10% owner
Buy49,771USD 78.57US$3.91MSep 28, 2026
Julian C. Baker
Director, 10% owner
Buy534USD 79.40US$42,400Sep 28, 2026
Julian C. Baker
Director, 10% owner
Buy8,956USD 79.40US$711KSep 28, 2026

This page holds 50 of 100 trades. Open Shareholders

Big stakes

StakeStakeSharesDateFiling
Baker Bros. Advisors LP35.00%22MSep 28, 2026Schedule 13D
D. VICTOR PERLROTH, M.D.9.90%6.5MDec 31, 2025Schedule 13G
BlackRock, Inc.5.30%3.27MMar 31, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Richard Levy
Other companies: Protara Therapeutics, Inc. (Director · Since at least Jan 9, 2020); Kiniksa Pharmaceuticals International, plc (Director · Since at least Mar 4, 2019); Madrigal Pharmaceuticals, Inc. (Director · Since at least Jun 19, 2018); Constellation Pharmaceuticals Inc (Director · Apr 3, 2020 – Jul 15, 2021 · Past)
Director · Since at least Oct 3, 2018
Charles A. Bancroft
Other companies: Bristol-Myers Squibb Company (EVP, Head of Integration · Dec 31, 2019 – Mar 10, 2020 · Past); Colgate-Palmolive Company (Director · May 13, 2019 – May 13, 2019 · Past)
Chair of the Audit Committee · Since at least Apr 2, 2020
Robert A. Profusek
Other companies: CTS Corporation (Lead Independent Director · Since at least Nov 5, 2020); Valero Energy Corporation (Director · Apr 29, 2021 – May 15, 2024 · Past)
Director · Since at least Jun 30, 2021
Bassil I. Dahiyat
Other companies: Xencor, Inc. (President & Chief Executive Officer, Director · Since at least Dec 2, 2013)
Director · Since at least Oct 3, 2018

Open People

Log in to ask 6ix AI your own questions about Kodiak Sciences Inc.